| Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis (NCT05706220) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2022-06-13 |
| China National Registry of Neuro-Inflammatory Diseases (NCT05154370) | Beijing Tiantan Hospital | 2021-12-15 |
| MS-ResearchBiomarkerS (NCT05204459) | Cedars-Sinai Medical Center | 2021-11-11 |
| Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis (NCT04798651) | University Hospital, Bordeaux | 2021-09-30 |
| A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab (NCT04998851) | Hoffmann-La Roche | 2021-09-16 |
| Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System (NCT04599023) | Insel Gruppe AG, University Hospital Bern | 2020-10-16 |
| Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset (NCT04466150) | University of California, San Francisco | 2020-08-30 |
| Ocrelizumab in Breastmilk (NCT04387110) | University of California, San Francisco | 2020-08-07 |
| Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis (NCT04009005) | Terry L. Wahls | 2020-05-01 |
| Minocycline in MS: Confirmation of Benefit (NCT04291456) | University of Calgary | 2020-01-31 |
| Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome (NCT03979391) | Lille Catholic University | 2019-09-26 |
| Understanding Magnetic Resonance Imaging in Multiple Sclerosis (NCT03872583) | Universitätsklinikum Hamburg-Eppendorf | 2019-03-15 |
| Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI (NCT03438357) | Centre Hospitalier Universitaire de Nīmes | 2019-01-02 |
| Risk Factors in Early Multiple Sclerosis (NCT03586986) | University of Colorado, Denver | 2018-07-26 |
| Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients (NCT03610139) | American University of Beirut Medical Center | 2018-05-21 |
| The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS (NCT03451955) | University of Copenhagen | 2018-01-19 |
| Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography (NCT04705610) | Association de Recherche Bibliographique pour les Neurosciences | 2017-05-23 |
| Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) (NCT06940323) | University of California, San Francisco | 2017-03-21 |
| Clinical Importance of Glucose Regulation in Relapsing MS (NCT03004079) | University of Virginia | 2016-10-01 |
| Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis (NCT02671682) | Albert Christian Ludolph, Prof. | 2016-02-26 |
| Mitochondrial Dysfunction and Disease Progression (NCT02549703) | Icahn School of Medicine at Mount Sinai | 2015-09-01 |
| Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™ (NCT02254304) | Merck KGaA, Darmstadt, Germany | 2014-12-31 |
| Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS) (NCT03541226) | University Hospital, Lille | 2014-09-01 |
| Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome (NCT01728922) | University College Dublin | 2012-11-06 |
| A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis (NCT01737372) | John F. Foley, MD | 2012-11-01 |
| Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion (NCT02043964) | Lille Catholic University | 2012-10-01 |
| Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS) (NCT01039103) | Lakefront Biotherapeutics NV | 2009-12-01 |
| Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) (NCT00813709) | Merck KGaA, Darmstadt, Germany | 2008-12-01 |
| Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta (NCT00819897) | Centre Hospitalier Universitaire de Nice | 2008-06-01 |
| AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS (NCT00617383) | The University of Texas Health Science Center, Houston | 2008-02-01 |
| Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis (NCT00595920) | Opexa Therapeutics, Inc. | 2007-11-01 |
| A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome (NCT00287079) | Merck KGaA, Darmstadt, Germany | 2005-10-01 |
| Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS (NCT00232193) | Providence Multiple Sclerosis Center | 2003-12-01 |